Stockpiling at the Onset of the COVID-19 Pandemic: An Empirical Analysis of National Prescription Drug Sales and Prices
- Minje Park ,
Corresponding Author
Minje Park
[email protected]https://orcid.org/0000-0002-8385-0857
Decision, Risk, and Operations, Columbia Business School, New York, New York 10027;
- Anita L. Carson ,
Anita L. Carson
[email protected]https://orcid.org/0000-0001-9765-7372
Operations and Technology Management, Questrom School of Business, Boston University, Boston, Massachusetts 02215;
- Erin R. Fox ,
Erin R. Fox
[email protected]https://orcid.org/0000-0003-0070-0501
Drug Information, Pharmacy Informatics, Safety and Quality, and Support Services, University of Utah Health, Salt Lake City, Utah 84132;
- Rena M. Conti
Rena M. Conti
[email protected]https://orcid.org/0000-0002-4190-1839
Markets, Public Policy, and Law, Questrom School of Business, Boston University, Boston, Massachusetts 02215;Technology & Policy Research Initiative, Boston University, Boston, Massachusetts 02215
Corresponding Author
Minje Park
[email protected]https://orcid.org/0000-0002-8385-0857
Decision, Risk, and Operations, Columbia Business School, New York, New York 10027;
Anita L. Carson
[email protected]https://orcid.org/0000-0001-9765-7372
Operations and Technology Management, Questrom School of Business, Boston University, Boston, Massachusetts 02215;
Erin R. Fox
[email protected]https://orcid.org/0000-0003-0070-0501
Drug Information, Pharmacy Informatics, Safety and Quality, and Support Services, University of Utah Health, Salt Lake City, Utah 84132;
Rena M. Conti
[email protected]https://orcid.org/0000-0002-4190-1839
Markets, Public Policy, and Law, Questrom School of Business, Boston University, Boston, Massachusetts 02215;Technology & Policy Research Initiative, Boston University, Boston, Massachusetts 02215
Supplemental Material
The replication files for this article are available HERE.

